GetPortalImpactFactorByIdResp(projectId=1, id=9aa5761, cover=https://img.medsci.cn/images/journal/cover/2021/Qdk_202109271314503470.jpg, fullname=Current Vascular Pharmacology, abbr=CURR VASC PHARMACOL, pyear=2003, frequence=Quarterly, articleNumbers=542, citedSelf2015=10.1, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均2月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1570-1611, greenSci=https://www.greensci.net/search?kw=1570-1611, scijournal=https://www.scijournal.org/impact-factor-of-CURR-VASC-PHARMACOL.shtml, medsciHotlightString=null, medsciHotlightRealtime=2.79, medsciHotlight=2.277, medsciHotlight5year=2.81134, citescore=5.7, hIndex=60, impactFactor=4.5, orgnization=Bentham Science Publishers B.V., orgnizationUrl=http://www.bentham.org/, country=United Arab Emirates, countryCn=阿联酋, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|Current Contents - Clinical Medicine|Current Contents - Life Sciences|BIOSIS Previews|BIOSIS Reviews Reports And Meetings, bigclassCas=医学 4区, smallclassCas=医学 4 区, website=https://www.benthamscience.com/journal/cvp, websiteHits=5766, guideForAuthor=https://www.benthamscience.com/journal/40/ifa, guideForAuthorHits=77, submitWebsite=https://bentham.manuscriptpoint.com/journals/cvp, submitWebsiteHits=1293, content=<p>Published by Bentham Science Publishers. ISSN: 1570-1611.<br /><br />Vascular disease is the commonest cause of death in Westernized countries and its incidence is on the increase in developing countries. It follows that considerable research is directed at establishing effective treatment for acute vascular events. Long-term treatment has also received considerable attention (e.g. for symptomatic relief). Furthermore, effective prevention, whether primary or secondary, is backed by the findings of several landmark trials. Vascular disease is a complex field with primary care physicians and nurse practitioners as well as several specialties involved. The latter include cardiology, vascular and cardio thoracic surgery, general medicine, radiology, clinical pharmacology and neurology (stroke units). Current Vascular Pharmacology will publish reviews to update all those concerned with the treatment of vascular disease. For example, reviews commenting on recently published trials or new drugs will be included. In addition to clinically relevant topics we will consider 'research-based' reviews dealing with future developments and potential drug targets. Therefore, another function of Current Vascular Pharmacology is to bridge the gap between clinical practice and ongoing research. Debates will also be encouraged in the correspondence section of this journal.</p>, totalCites=2439, brief=CURR VASC PHARMACOL杂志医学行业，“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的优秀级杂志, articleType=该刊全部是论著，可能不接收综述类等文章, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=CURR VASC PHARMACOL杂志级别还可以，但是相对来说，比较冷门，关注人数偏少，有些可能是国内不太熟悉，但该杂志在国际仍然有相当知晓度的。因为缺少中国人投稿，稿源可能未必丰富，发表有可能有很大的机会哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=9aa5761'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=43731, tagName=血管药理, createdHits=2), ImpactFactorTagDto(id=27394, tagName=药理学, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=1.91), GetImpactFactorCiteScoreListResponse(year=2017, citescore=1.75), GetImpactFactorCiteScoreListResponse(year=2018, citescore=1.86), GetImpactFactorCiteScoreListResponse(year=2019, citescore=4.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=5.7)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=2.75), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=1.952), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=2.299), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=2.624), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=2.79)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Cardiology and Cardiovascular Medicine , rank=109/322), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=165/300)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PERIPHERAL VASCULAR DISEASE, rank=Q2), GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q2)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1570-1611[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CURRENT VASCULAR PHARMACOLOGY[ta], article_number=60, article_number_cn=7, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)